Nouveau Life Company Insiders

NOUV Stock  USD 0.0001  0.0001  50.00%   
Nouveau Life employs about 7 people. The company is managed by 5 executives with a total tenure of roughly 31 years, averaging almost 6.0 years of service per executive, having 1.4 employees per reported executive. Recap of Nouveau Life's management performance can provide insight into the venture performance.
Rolly Hein  President
Vice President Treasurer, Secretary, Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nouveau Life Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Nouveau Life Management Team Effectiveness

The company has return on total asset (ROA) of (0.1983) % which means that it has lost $0.1983 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1952) %, meaning that it created substantial loss on money invested by shareholders. Nouveau Life's management efficiency ratios could be used to measure how well Nouveau Life manages its routine affairs as well as how well it operates its assets and liabilities.

Nouveau Life Workforce Comparison

Nouveau Life Pharmaceuticals is considered to be number one stock in number of employees category among its peers. The total workforce of Shell Companies industry is now estimated at about 10,739. Nouveau Life adds roughly 7.0 in number of employees claiming only tiny portion of equities listed under Shell Companies industry.

Nouveau Life Pharmac Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Nouveau Life Pharmac Price Series Summation is a cross summation of Nouveau Life price series and its benchmark/peer.

Nouveau Life Notable Stakeholders

A Nouveau Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nouveau Life often face trade-offs trying to please all of them. Nouveau Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nouveau Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Rolly HeinVice President Treasurer, Secretary, DirectorProfile
Douglas DickieChief DirectorProfile
Darcy PennerMa RelationsProfile
Brian ShibleyCEO ChairmanProfile
Warren WheelerS TreasurerProfile

About Nouveau Life Management Performance

The success or failure of an entity such as Nouveau Life Pharmac often depends on how effective the management is. Nouveau Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nouveau management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nouveau management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc. Nouveau Life is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Nouveau Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nouveau Life Pharmaceuticals. Check Nouveau Life's Beneish M Score to see the likelihood of Nouveau Life's management manipulating its earnings.

Nouveau Life Workforce Analysis

Traditionally, organizations such as Nouveau Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nouveau Life within its industry.

Nouveau Life Manpower Efficiency

Return on Nouveau Life Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee51K
Net Loss Per Executive71.4K

Additional Tools for Nouveau Pink Sheet Analysis

When running Nouveau Life's price analysis, check to measure Nouveau Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nouveau Life is operating at the current time. Most of Nouveau Life's value examination focuses on studying past and present price action to predict the probability of Nouveau Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nouveau Life's price. Additionally, you may evaluate how the addition of Nouveau Life to your portfolios can decrease your overall portfolio volatility.